Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
RE ›
RECALMAX
Trademark search for:
RECALMAX
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-02-02 — Application filed
2017-02-06 — Application filed
2017-02-07 — Application filed
2017-03-10 — Assigned to examiner
2017-03-21 — Final disposition recorded
2017-03-21 — Final disposition recorded
2017-03-21 — Final disposition recorded
2017-07-27 — Teas revoke/app/change addr of atty/dom rep received
2017-07-27 — Attorney/dom.rep.revoked and/or appointed
2017-09-05 — Office action issued
2017-09-05 — Correspondence received in law office
2017-09-06 — Teas/email correspondence entered
2017-09-26 — Suspension letter written
2017-09-26 — Notification of letter of suspension e-mailed
2017-09-26 — Letter of suspension e-mailed
2017-11-08 — Teas change of correspondence received
2017-11-08 — Teas change of owner address received
2017-11-08 — Applicant/correspondence changes (non-responsive) entered
2018-03-26 — Report completed suspension check case still suspended
2018-10-17 — Assigned to lie
2018-10-18 — Suspension checked - to attorney for action
2018-11-19 — Office action issued
2018-11-19 — Office action issued
2018-11-19 — Office action issued
2019-05-13 — Exparte appeal received at ttab
2019-05-13 — Jurisdiction restored to examining attorney
2019-05-13 — Ex parte appeal-instituted
2019-05-13 — Teas request for reconsideration received
2019-05-15 — Correspondence received in law office
2019-05-15 — Teas/email correspondence entered
2019-06-07 — Final disposition recorded
2019-06-07 — Action denying req for recon e-mailed
2019-06-07 — Notification of action denying req for recon e-mailed
2019-07-18 — Exparte appeal dismissed
2019-07-18 — Exparte appeal terminated
2019-07-24 — Application abandoned
2019-07-24 — Application abandoned
2019-07-24 — Final status recorded
Owner Information
Innovus Pharmaceuticals, Inc.
Correspondent
RANDY BERHOLTZ INNOVUS PHARMACEUTICALS INC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
